HRTX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own HRTX shares is 204, representing 79.45% of the company's common stock.

GSA CAPITAL PARTNERS LLP, in the last quarter, reduced its stake in HRTX by -17.6% restricting it's holding to 279.7 thousand shares of worth nearly $775.00K. MORGAN STANLEY also lessened -56.94% of the HRTX shares from its portfolio, reducing its holding to 199 thousand shares of worth $551.23K. ALLIANCEBERNSTEIN L.P. also shunned HRTX shares holding by -14.77% last quarter which brought its holding to 165.03 thousand shares worth $457.13K.

As per its latest 13F filing, XTX TOPCO LTD increased its stake in HRTX by 100.23% in the last quarter. The institutional holder raised its holding to 208.79 thousand shares having worth more than $578.34K. PANAGORA ASSET MANAGEMENT INC also added 169.87% more shares of HRTX to its portfolio, raising its holding to 375.43 thousand shares of worth $1.04M. SUSQUEHANNA INTERNATIONAL GROUP, LLP also increased its HRTX shares holding by 168.54% which brought its holding to 185.9 thousand shares worth $514.94K.

The insider with the most stakes in HRTX is SPCH, LLLP , 10 percent owner at the company. Additionally, HRTX stock is highly held by director TANG KEVIN C and director Morgan Adam among others.

Company executives, directors, and other insiders own 0.86% percent of Heron Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which HRTX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include MANHARD KIMBERLY, CHRISTIAN WAAGE, and JOHNSON CRAIG A.

There have been 0 transaction(s) during the past 6-months in which Heron Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 Heron Therapeutics, Inc. shares are held by insiders, which represents about 0.86% of HRTX stock.

HRTX 10 percent owner, SPCH, LLLP holds the largest portfolio of the company's shares. HRTX shares owned by SPCH, total nearly 38.1 million.

XTX TOPCO LTD is the largest institutional owner in HRTX which holds 208.79 thousand shares worth $578.34K or 0.14% of the total HRTX shares outstanding followed by PANAGORA ASSET MANAGEMENT INC with ownership of 375.43 thousand shares representing 0.25% of the HRTX ownership. KBC GROUP NV is the third largest stakeholder with 289.27 thousand shares or 0.19% of the ownership worth more than $801.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the HRTX is concerned, it is a stock which is optionable.

Number of HRTX shares short is 30.71M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 152.10M shares of HRTX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, HRTX has 116.15M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for HRTX is 5.11.